MicroRNA-410 acts as oncogene in NSCLC through downregulating SLC34A2 via activating Wnt/β-catenin pathway | |
Zhang, X.; Ke, X.; Pu, Q.; Yuan, Y.; Yang, W.; Luo, X.; Jiang, Q.; Hu, X.; Gong, Y.; Tang, K. | |
刊名 | Oncotarget
![]() |
2016 | |
卷号 | Vol.7 No.12页码:14569-14585 |
关键词 | MiR-410 NSCLC SLC34A2 Tumorigenesis and development |
ISSN号 | 1949-2553 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/1819842 |
专题 | 四川大学 |
作者单位 | 1.a State Key Laboratory of Biotherapy, Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China 2.Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China |
推荐引用方式 GB/T 7714 | Zhang, X.,Ke, X.,Pu, Q.,et al. MicroRNA-410 acts as oncogene in NSCLC through downregulating SLC34A2 via activating Wnt/β-catenin pathway[J]. Oncotarget,2016,Vol.7 No.12:14569-14585. |
APA | Zhang, X..,Ke, X..,Pu, Q..,Yuan, Y..,Yang, W..,...&Wei, Y..(2016).MicroRNA-410 acts as oncogene in NSCLC through downregulating SLC34A2 via activating Wnt/β-catenin pathway.Oncotarget,Vol.7 No.12,14569-14585. |
MLA | Zhang, X.,et al."MicroRNA-410 acts as oncogene in NSCLC through downregulating SLC34A2 via activating Wnt/β-catenin pathway".Oncotarget Vol.7 No.12(2016):14569-14585. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论